Dramatic Response to Cardiac Resynchronization Therapy With AV Delay Optimization in Narrow QRS Heart Failure
Rikitake Kogawa1, Toshiko Nakai, Yukitoshi Ikeya
1Division of Cardiology, Department of Medicine, Nihon University School of Medicine.
International Heart Journal
|November 10, 2015
Summary
Cardiac resynchronization therapy (CRT) can benefit heart failure patients with narrow QRS complexes. Optimizing atrioventricular (AV) delay is crucial for successful CRT outcomes in these specific cases.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Cardiac resynchronization therapy (CRT) is a key treatment for heart failure, but its efficacy in patients with narrow QRS complexes is debated.
- Current guidelines suggest CRT is not strongly recommended for patients presenting with a narrow QRS complex.
Observation:
- A 61-year-old male with dilated cardiomyopathy and intractable heart failure despite optimal medical management presented with a narrow QRS complex.
- Initial CRT implantation resulted in QRS widening and clinical deterioration, necessitating re-evaluation.
Findings:
- Optimizing the atrioventricular (AV) delay post-CRT implantation led to a significant reduction in QRS duration and a dramatic improvement in the patient's heart failure symptoms.
- The patient experienced sustained clinical improvement and avoided further hospitalizations after AV delay optimization.
Implications:
- This case highlights the potential benefit of CRT in select heart failure patients with narrow QRS complexes.
- Individualized AV delay optimization is critical for achieving successful CRT outcomes and improving patient prognosis in this population.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
1.9K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.3K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.3K
Cardiomyopathy II: Dilated Cardiomyopathy
757
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
757
Heart Failure V: Medical Management
532
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
532
Heart Failure VI: Adjunct Therapies
568
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
568
Heart Failure IV: Classification and Diagnostic Evaluation
594
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
594


